Sukumar S - Search Results

1

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

Connolly RM, Fackler MJ, Zhang Z, Zhou XC, Goetz MP, Boughey JC, Walsh B, Carpenter JT, Storniolo AM, Watkins SP, Gabrielson EW, Stearns V, Sukumar S. Connolly RM, et al. Among authors: sukumar s. Breast Cancer Res Treat. 2018 Jan;167(1):107-116. doi: 10.1007/s10549-017-4503-2. Epub 2017 Sep 16. Breast Cancer Res Treat. 2018. PMID: 28918548 Free PMC article. Clinical Trial.

2

Absence of TSG101 transcript abnormalities in human cancers.

Trink B, Pai SI, Spunt SL, Raman V, Cairns P, Jen J, Gabrielson E, Sukumar S, Sidransky D. Trink B, et al. Among authors: sukumar s. Oncogene. 1998 May 28;16(21):2815-8. doi: 10.1038/sj.onc.1201795. Oncogene. 1998. PMID: 9652749

3

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S. Dome JS, et al. Among authors: sukumar s. Cancer Res. 1999 Sep 1;59(17):4301-7. Cancer Res. 1999. PMID: 10485476

4

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Loeb DM, et al. Among authors: sukumar s. Cancer Res. 2001 Feb 1;61(3):921-5. Cancer Res. 2001. PMID: 11221883

5

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Evron E, et al. Among authors: sukumar s. Cancer Res. 2001 Mar 15;61(6):2782-7. Cancer Res. 2001. PMID: 11289162

6

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S. Evron E, et al. Among authors: sukumar s. Lancet. 2001 Apr 28;357(9265):1335-6. doi: 10.1016/s0140-6736(00)04501-3. Lancet. 2001. PMID: 11343741

7

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Umbricht CB, et al. Among authors: sukumar s. Oncogene. 2001 Jun 7;20(26):3348-53. doi: 10.1038/sj.onc.1204438. Oncogene. 2001. PMID: 11423985

8

CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.

Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V. Li B, et al. Among authors: sukumar s. Cancer Res. 2001 Nov 1;61(21):8014-21. Cancer Res. 2001. PMID: 11691827

9

Novel agents for chemoprevention, screening methods, and sampling issues.

Fackler MJ, Evron E, Khan SA, Sukumar S. Fackler MJ, et al. Among authors: sukumar s. J Mammary Gland Biol Neoplasia. 2003 Jan;8(1):75-89. doi: 10.1023/a:1025735405628. J Mammary Gland Biol Neoplasia. 2003. PMID: 14587864 Review.

10

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. Fackler MJ, et al. Among authors: sukumar s. Int J Cancer. 2003 Dec 20;107(6):970-5. doi: 10.1002/ijc.11508. Int J Cancer. 2003. PMID: 14601057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters